申请人:AVENTIS PHARMA DEUTSCHLAND GMBH
公开号:US20040171604A1
公开(公告)日:2004-09-02
This invention is directed to the compound of formula (I) which is useful for inhibiting the activity of Factor Xa. The present invention is also directed to compositions containing said compounds, processes for their preparation, their use, such as in inhibiting the formation of thrombin or for therapeutically or prophylactically treating a patient suffering from, or subject to, or associated with a disease state associated with a cardiovascular disorder.
本发明涉及一种化合物(I),其可用于抑制Xa因子的活性。本发明还涉及含有该化合物的组合物、其制备过程、其用途,例如抑制凝血酶形成或用于治疗或预防患有与心血管疾病相关联的疾病状态的患者。